![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Weiss, L.; Karthaus, M.; Riera-Knorrenschild, J.; Kretzschmar, A.; Welslau, M.; Vehling-Kaiser, U.; Pelz, H.; Ettrich, T. J.; Hess, J.; Reislaender, T.; Klein, A. und Heinemann, V
(2022):
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial.
In: Esmo Open, Bd. 7, Nr. 1
[PDF, 367kB]
2020
Kurreck, A.; Geissler, M.; Martens, U. M.; Riera-Knorrenschild, J.; Greeve, J.; Florschütz, A.; Wessendorf, S.; Ettrich, T.; Kanzler, S.; Nörenberg, D.; Seidensticker, M.; Held, S.; Buechner-Steudel, P.; Atzpodien, J.; Heinemann, V.; Stintzing, S.; Seufferlein, T.; Tannapfel, A.; Reinacher-Schick, A. C. und Modest, D. P.
(2020):
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109).
In: Journal of Cancer Research and Clinical Oncology, Bd. 146, Nr. 10: S. 2681-2691
2018
Thomas, M.; Ponce-Aix, S.; Navarro, A.; Riera-Knorrenschild, J.; Schmidt, M.; Wiegert, E.; Kapp, K.; Wittig, B.; Mauri, C.; Gomez, M. Domine; Kollmeier, J.; Sadjadian, P.; Froehling, K.-P.; Huber, R. M.; Wolf, M.; Pall, Georg; Surmont, Veerle; Bosquee, Leon; Germonpre, Paul; Brückl, Wolfgang; Grah, Christina; Herzmann, Christian; Leistner, Rumo; Meyer, Andreas; Müller, Lothar; Schmalz, Oliver; Scholz, Christian; Schröder, Michael; Serke, Monika; Wesseler, Claas; Brandts, Christian; Kopp, Hans-Georg; Blau, Wolfgang; Griesinger, Frank; Garcia Campelo, Maria Rosario; Garcia Garcia, Yolanda und Trigo Perez, Jose Manuel
(2018):
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.
In: Annals of Oncology, Bd. 29, Nr. 10: S. 2076-2084
2016
Thomas, M.; Carter, R.; Aix, S. Ponce; Riera-Knorrenschild, J.; Mendivil, A. Navarro; Domine, M.; Kollmeier, J.; Sadjadian, P.; Huber, R. M. und Wolf, M.
(2016):
Immune surveillance reactivation to improve overall survival in small cell lung cancer (SCLC): The randomized IMPULSE study.
In: Annals of Oncology, Bd. 27